₩5590.00
₩-60.00 (-1.06%)
End-of-day quote: 05/16/2024
KOSE:A005690
Pharmicell Annual Report
| Year | Year | 2013 | 2012 | |||
|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩33.41B | ₩11.11B | ||
| GM % | Gross Margin % |
|
25.97% | 11.32% | ||
| OM | Operating Margin |
|
-23.49% | -128.24% | ||
| EPS | Earnings Per Share |
|
₩0.00 | ₩294.00 | ₩-608.00 | ₩-467.00 |
| Div. | Dividends |
|
₩0.00 | ₩0.00 | ||
| PR % | Payout Ratio % |
|
0 | 0 | ||
| Sha. | Shares |
|
43.39m | 41.86m | ||
| OCF | Operating Cash Flow |
|
₩-2687.73M | ₩-11868.35M | ||
| FCF | Free Cash Flow |
|
₩-3166.72M | ₩-14348.15M | ||
| FCFS | Free Cash Flow Per Share |
|
₩-126.32 | ₩-395.43 |
